Variable | BALF CMV positive (n = 57) | BALF CMV negative (n = 54) | P-value |
---|---|---|---|
Age, median (IQR), months | 11.0 (6.0–21.5) | 14.5 (9.7–23.0) | 0.133 |
Male, n (%) | 42 (73.7) | 43 (79.6) | 0.460 |
Breastfeeding, n (%) | 35 (61.4) | 30 (55.6) | 0.532 |
≥ 2 children in household, n (%) | 34 (59.6) | 37 (68.5) | 0.331 |
Length of hospitalization, median (IQR), days | 11.0 (9.0–13.2) | 11.0 (8.0–13.0) | 0.001 |
Peripheral blood eosinophils, median (IQR), % | 0.7 (0.3–1.3) | 0.9 (0.2–2.3) | 0.385 |
IgE, median (IQR), IU/mL | 77.1 (11.1–132.2) | 46.4 (9.2–160.6) | 0.833 |
Subpopulation of lymphocytes, median (IQR), % | |||
CD19+CD23+ | 13.6 (10.5–19.4) | 13.3 (9.9–18.1) | 0.383 |
CD3+ | 61.3 (52.4–70.9) | 65.1 (52.6–70.3) | 0.626 |
CD3+ CD4+ | 35.0 (26.9–39.7) | 35.3 (31.4–45.1) | 0.063 |
CD3+CD8+ | 24.3 (17.6–28.6) | 18.5 (15.6–26.2) | 0.023 |
CD3−CD16+CD56+ | 9.6 (6.3–13.1) | 8.9 (5.4–11.7) | 0.647 |
CD3−CD19+ | 24.6 (18.2–31.1) | 21.9 (17.6–30.6) | 0.482 |
Humoral immunity, median (IQR), g/L | |||
Total IgA | 0.43 (0.16–0.66) | 0.32 (0.16–0.59) | 0.273 |
Total IgM | 0.89 (0.68–1.46) | 0.9 (0.63–1.36) | 0.700 |
Total IgG | 6.09 (4.91–7.93) | 5.73 (4.25–7.92) | 0.254 |
Cytology of BALF, median (IQR), % | |||
Macrophages | 50.0 (13.5–87.0) | 54.0 (24.5–82.5) | 0.554 |
Neutrophils | 38.0 (10.0–77.5) | 36.5 (12.0–62.0) | 0.437 |
Lymphocytes | 4.0 (2.0–9.5) | 5.0 (2.0–6.7) | 0.954 |
Eosinophils | 0.0 (0.0–2.0) | 0.5 (0.0–6.0) | 0.027 |